A compound having the general structure shown in Formula I:
or pharmaceutically acceptable salts and/or solvates thereof are useful in treating diseases or conditions mediated by NK1 receptors, for example various physiological disorders, symptoms or diseases, including emesis, depression, anxiety and cough.
具有式 I 所示一般结构的化合物:
或其药学上可接受的盐和/或溶解物,可用于治疗由 NK1 受体介导的疾病或病症,例如各种生理紊乱、症状或疾病,包括呃逆、抑郁、焦虑和咳嗽。
Dimethylamine as a Substrate in Hydroaminoalkylation Reactions
作者:Jens Bielefeld、Sven Doye
DOI:10.1002/anie.201708959
日期:2017.11.20
Size matters: For the first time since catalytic hydroaminoalkylation chemistry started 37 years ago, dimethylamine can efficiently be added to alkenes using an inexpensive and easilyobtainable Ti catalyst. The size of the flask determines whether the reaction gives monohydroaminoalkylation or dihydroaminoalkylation.